Boricua accepted into prestigious genetic technology program in San Francisco
Submitted by Ariadna S. Rubio Lebrón on
The Medical Sciences Campus student will do her internship at an innovative company that is a pioneer in the success and expansion of biotechnology at a global level.
San Juan, Puerto Rico - Rachell Martínez Ramírez, a student of the Medical Sciences Campus (RCM) of the University of Puerto Rico, was selected to participate in the prestigious and competitive post-doctoral internship program at Genentech Biopharmaceuticals, located in San Francisco.
Genetech is considered a pioneer in the success and expansion of biotechnology globally. It is dedicated to the development of innovative science and treatments for terminally ill patients. The entity is recognized for creating the first anti-cancer antibody and the first drug to treat primary progressive multiple sclerosis.
"I am very grateful for this opportunity. Doing postdoctoral studies at the leading biotechnology company is certainly a challenge and a motivation to continue giving my best. Thanks to my colleagues and mentors at the Campus for their support," said Rachell Martínez.
For his part, Dr. Abel Baerga, Rachell's mentor and professor in the Department of Biochemistry at the RCM School of Medicine, emphasized that "this achievement demonstrates that students in the Medical Sciences Campus doctoral programs are highly qualified to conduct medical research at the highest levels. And Rachell is a living example of that excellence".